epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Cardiovascular

Subclasses

  • Aldosterone Synthase Inhibitors
  • Alpha Agonists, Cardiovascular
  • Alpha Blockers, Peripheral
  • Angiotensin Receptor Blocker (ARB)/ Thiazide Combos
  • Angiotensin Receptor Blockers (ARBs)
  • Angiotensin-Converting Enzyme (ACE) Inhibitor/ Thiazide Combos
  • Angiotensin-Converting Enzyme (ACE) Inhibitors
  • Antianginals
  • Antiarrhythmics, Intranasal
  • Antiarrhythmics, Oral
  • Antiarrhythmics, Parenteral
  • Anticoagulant Reversal Agents
  • Anticoagulants
  • Antiplatelets, Cardiovascular
  • Beta Blocker/ Thiazide Combos
  • Beta Blockers
  • Calcium Channel Blockers (CCBs), Dihydropyridines
  • Calcium Channel Blockers (CCBs), Non-dihydropyridines
  • Cardiac Amyloidosis
  • Cardiovascular Inflammation
  • CHAPLE Disease
  • Claudication
  • Colloids
  • Diagnostic Agents, Cardiovascular
  • Direct Renin Inhibitors
  • Diuretics, Carbonic Anhydrase Inhibitors
  • Diuretics, Loop
  • Diuretics, Osmotic
  • Diuretics, Potassium-sparing
  • Diuretics, Thiazides
  • Dyslipidemia: Adenosine Triphosphate-Citrate Lyase (ACL) Inhibitors
  • Dyslipidemia: Angiopoietin-Like 3 (ANGPTL3) Inhibitors
  • Dyslipidemia: Apolipoprotein C-III (APOC3) Inhibitors
  • Dyslipidemia: Bile Acid Sequestrants
  • Dyslipidemia: Cholesterol Absorption Inhibitors
  • Dyslipidemia: Fibrates
  • Dyslipidemia: HMG-CoA Reductase Inhibitors (Statins)
  • Dyslipidemia: MTP Inhibitors
  • Dyslipidemia: Niacin
  • Dyslipidemia: Omega-3 Fatty Acids
  • Dyslipidemia: PCSK9 Inhibitors
  • Dyslipidemia: PCSK9 Small Interfering Ribonucleic Acids (siRNAs)
  • Endothelin Receptor Antagonists, Cardiovascular
  • GLP-1 Agonists, Cardiovascular
  • HCN Channel Blockers
  • Hypertrophic Cardiomyopathy: Ablative Agents
  • Hypertrophic Cardiomyopathy: Cardiac Myosin Inhibitors
  • Inotropes/ Pressors
  • Mineralocorticoid (Aldosterone) Receptor Antagonists
  • Mineralocorticoid Receptor Antagonists, Nonsteroidal
  • Mitochondrial Diseases, Cardiovascular
  • Neprilysin Inhibitors
  • Patent Ductus Arteriosus
  • Pulmonary Arterial Hypertension (PAH)
  • Sclerosing Agents, Vascular
  • SGLT1 Inhibitors, Cardiovascular
  • SGLT2 Inhibitors, Cardiovascular
  • soluble Guanylate Cyclase (sGC) Stimulators
  • Thrombolytics, Oligonucleotides
  • Thrombolytics, Recombinant Tissue Plasminogen Activators (rtPA)
  • Tyrosine Hydroxylase Inhibitors
  • Vasodilators/ Nitrates

Pulmonary Arterial Hypertension (PAH)

Drug Names

Generic Names

Adcirca tadalafil  
Adempas riociguat  
Alyq tadalafil  
ambrisentan generic  
bosentan generic  
epoprostenol generic  
Flolan epoprostenol  
Genosyl nitric oxide inhaled  
Inomax nitric oxide inhaled  
Letairis ambrisentan  
Liqrev sildenafil  
Noxivent nitric oxide inhaled  
Opsumit macitentan  
Opsynvi macitentan/ tadalafil  
Orenitram treprostinil  
Remodulin treprostinil  
Revatio sildenafil  
sildenafil generic  
tadalafil generic  
Tadliq tadalafil  
Tracleer bosentan  
treprostinil generic  
Tyvaso treprostinil inhaled  
Tyvaso DPI treprostinil inhaled  
Ulspira nitric oxide inhaled  
Uptravi selexipag  
Veletri epoprostenol  
Ventavis iloprost inhaled  
Winrevair (sotatercept-csrk) sotatercept  
Yutrepia treprostinil inhaled  

close

 

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information